Thyroid dysfunction during treatment with systemic antineoplastic therapy for childhood cancer

This is a protocol for a Cochrane Review (intervention). The objectives are as follows:

To gain insight into the occurrence of and risk factors for aberrant thyroid function parameters (i.e. TSH, free thyroxine (FT4)) as expression of hypothyroidism, hyperthyroidism, or NTI during cancer treatment in children treated with systemic antineoplastic therapy.

This is a protocol.